Deal Spree Continues as Celgene Nabs Juno in $9B Deal Post author:Sam Post published:January 21, 2018 Post category:BioPharma The announcement sent shares of Juno soaring more than 27 percent in pre-market trading to $86.26. Source: BioSpace You Might Also Like SYGNIS Reports Financial Results For The Second Quarter And First Six Months Of 2017 August 2, 2017 AbbVie Scores Key Trial Win for RA Drug With One Fatal Event Reported December 19, 2017 Sanofi: Availability Of The Pre-Quarterly Results Communication July 12, 2017